PER
Click for more information
10.5% 7.4¢ percheron therapeutics limited

FDA review re Sarepta 21/6/24 expanded gene therapy, page-2

  1. Akki
    35,735 Posts.
    lightbulb Created with Sketch. 554
    clock Created with Sketch.
    20/02/24
    14:26
    Post #: 72500357
    lol FDA is not going to do what some broker says - FDA will do as FDA will do ....


    I do think 5051 will probably phase out Exondy's though given the drastic increase - that meetings Q3
    PER Price at posting: 7.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS A Super PITch is key in the competition for capital
right-arrow Created with Sketch.
SS1 Sun Silver hits silver grades above 200g/t in early-stage portable scanner analysis
right-arrow Created with Sketch.
VMT Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth
right-arrow Created with Sketch.
BOE Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
right-arrow Created with Sketch.
NEWS Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
right-arrow Created with Sketch.
MGU Collaboration in a green (steel) future the focus for Magnum and Saudi partners
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.4¢ 		Change
0.007(10.5%) 		Mkt cap ! $66.71M
Open High Low Value Volume
6.5¢ 7.5¢ 6.3¢ $91.29K 1.309M

Buyers (Bids)

No. Vol. Price($)
1 49999 7.4¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 75476 2
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.